← Back to Search

Deep Brain Stimulation for Parkinson's Disease

N/A

Waitlist Available

Led By Mark R Richardson

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects 18-85 years old

Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of single dbs surgery

Awards & highlights

Study Summary

This trial will study brain activity in Parkinson's patients with deep brain stimulation to improve speech perception and production.

Who is the study for?

This trial is for English-speaking adults aged 18-85 with Parkinson's Disease who are scheduled for Deep Brain Stimulation (DBS) implantation. Participants must be able to understand the study and follow instructions.Check my eligibility

What is being tested?

The study aims to gather data on brain activity related to speech in Parkinson's patients during DBS. Researchers will use this information to better understand how DBS affects speech perception and production.See study design

What are the potential side effects?

Since the intervention involves collecting brain signal data rather than a medical treatment, traditional side effects are not applicable. However, there may be risks associated with standard DBS procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 85 years old.

Select...

I am scheduled for a DBS implant for my Parkinson's disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of single dbs surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of single dbs surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of single dbs surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The number of subjects providing interpretable electrophysiological data during DBS surgery

Trial Design

1Treatment groups

Experimental Treatment

Group I: Brain signal data collectionExperimental Treatment1 Intervention

Collection of brain data during deep brain stimulation

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,933 Previous Clinical Trials

13,198,471 Total Patients Enrolled

Mark R RichardsonPrincipal InvestigatorMGH

Mark R Richardson, MD, PhDPrincipal InvestigatorMGH

Media Library

Brain signal data collection Clinical Trial Eligibility Overview. Trial Name: NCT04277689 — N/A

Parkinson's Disease Research Study Groups: Brain signal data collection

Parkinson's Disease Clinical Trial 2023: Brain signal data collection Highlights & Side Effects. Trial Name: NCT04277689 — N/A

Brain signal data collection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04277689 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial recruiting participants at present?

"The clinicaltrials.gov website attests that this trial, which was first posted on June 10th 2021, is no longer looking for volunteers. Fortunately there are 488 other studies actively recruiting patients at the moment."

Answered by AI

Are individuals of a certain age bracket able to participate in this medical research?

"The requirements for this medical trial stipulate that potential participants must be 18 to 85 years old. Additionally, there are 27 trials available specifically for minors and 485 separate studies designed for individuals over the age of 65."

Answered by AI

Do I meet the criteria to be a participant in this research endeavor?

"This clinical trial is seeking 30 individuals suffering from Parkinson's disease aged between 18 and 85. To be eligible, applicants must fulfill the following criteria: Patients aged between 18-85 years old."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation

Robert Mark Richardson 2021. "Deep Neural Network Approaches for Closed-Loop Deep Brain Stimulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04277689.

All > Parkinsons Disease > Parkinson Disease